scPharmaceuticals to Participate in Two Upcoming Investor Conferences

Rhea-AI Summary

scPharmaceuticals Inc. announced that its CEO will participate in two upcoming investor conferences. The first conference is the Jefferies London Healthcare Conference on November 14, 2023, where there will be a fireside chat at 12:00pm GMT. The second conference is the Craig-Hallum 14th Annual Alpha Select Conference on November 16, 2023, where there will be investor one-on-one meetings only. A webcast of the Jefferies' fireside chat will be available on the company's website.

BURLINGTON, Mass., Oct. 31, 2023 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, today announced that John Tucker, President & Chief Executive Officer, will participate in two upcoming investor conferences.

Event:

Jefferies London Healthcare Conference
Tuesday, November 14, 2023
Fireside chat: 12:00pm GMT / 7:00am EST

Craig-Hallum 14^th Annual Alpha Select Conference
Thursday, November 16, 2023
Investor one-on-one meetings only

A webcast of the Jefferies’ fireside chat can be accessed under “News & Events” in the Investor Relations section of the Company’s website, www.scPharmaceuticals.com.

About scPharmaceuticals
scPharmaceuticals is a pharmaceutical company focused on developing and commercializing products that are designed to reduce healthcare costs and improve health outcomes. The Company develops, internally and through strategic partnerships, innovative products and solutions that aim to expand and advance the outpatient care of select acute conditions. The Company’s lead programs focus on the subcutaneous, self-administration of IV-strength treatments in heart failure and infectious disease. scPharmaceuticals is headquartered in Burlington, MA. For more information, please visit www.scPharmaceuticals.com.

Katherine Miranda
scPharmaceuticals Inc., 781-301-6869
kmiranda@scpharma.com

Investors:
PJ Kelleher
LifeSci Advisors, 617-430-7579
pkelleher@lifesciadvisors.com

FAQ

What company announced its CEO's participation in investor conferences?

scPharmaceuticals Inc.

When is the Jefferies London Healthcare Conference?

The conference is on November 14, 2023.

What is the format of scPharmaceuticals' participation in the Craig-Hallum 14th Annual Alpha Select Conference?

scPharmaceuticals will have investor one-on-one meetings only at the conference.

Where can the webcast of the Jefferies' fireside chat be accessed?

The webcast can be accessed on the company's website under 'News & Events' in the Investor Relations section.